These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18596367)

  • 1. Erythropoietin and its receptor in breast cancer: putting together the pieces of the puzzle.
    Mannello F; Tonti GA
    Oncologist; 2008 Jul; 13(7):761-8. PubMed ID: 18596367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin biology in cancer.
    Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
    Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoiesis-stimulating agent use in cancer: preclinical and clinical perspectives.
    Arcasoy MO
    Clin Cancer Res; 2008 Aug; 14(15):4685-90. PubMed ID: 18676735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients.
    Ioka T; Tsuruoka S; Ito C; Iwaguro H; Asahara T; Fujimura A; Kusano E
    Clin Pharmacol Ther; 2009 Aug; 86(2):154-9. PubMed ID: 19458615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An erythropoietin autocrine/paracrine axis modulates the growth and survival of human prostate cancer cells.
    Jeong JY; Hoxhaj G; Socha AL; Sytkowski AJ; Feldman L
    Mol Cancer Res; 2009 Jul; 7(7):1150-7. PubMed ID: 19567780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin and erythropoietin receptor expression in human cancer.
    Acs G; Acs P; Beckwith SM; Pitts RL; Clements E; Wong K; Verma A
    Cancer Res; 2001 May; 61(9):3561-5. PubMed ID: 11325818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research advances in expression and functions of erythropoietin and erythropoietin receptor in cancers].
    Li M; Lu Y; Chen XQ
    Ai Zheng; 2008 Jun; 27(6):667-72. PubMed ID: 18570746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors.
    Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V
    Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mystery Story about Erythropoietin (Epo) and Erythropoietin Receptor (EpoR) are Disguised?
    Cubranić A; Redzovic A; Dobrila-Dintinjana R; Vukelić J; Dintinjana M
    Hepatogastroenterology; 2015 May; 62(139):585-9. PubMed ID: 26897933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M; Gross AW; Lodish HF
    Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of P53 and Bak with EPO and EPOR in human colorectal cancer.
    Baltaziak M; Koda M; Wincewicz A; Sulkowska M; Kanczuga-Koda L; Sulkowski S
    Anticancer Res; 2009 Oct; 29(10):4151-6. PubMed ID: 19846965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells.
    Lopez TV; Lappin TR; Maxwell P; Shi Z; Lopez-Marure R; Aguilar C; Rocha-Zavaleta L
    Int J Cancer; 2011 Dec; 129(11):2566-76. PubMed ID: 21442620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin-responsive sites in normal and malignant human lung tissues.
    Yasuda Y; Hara S; Hirohata T; Koike E; Yamasaki H; Okumoto K; Hoshiai H
    Anat Sci Int; 2010 Dec; 85(4):204-13. PubMed ID: 20397063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia.
    Osterborg A; Aapro M; Cornes P; Haselbeck A; Hayward CR; Jelkmann W
    Eur J Cancer; 2007 Feb; 43(3):510-9. PubMed ID: 17150352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression.
    Hedley BD; Allan AL; Xenocostas A
    Clin Cancer Res; 2011 Oct; 17(20):6373-80. PubMed ID: 21750199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The erythropoietin receptor and its expression in tumor cells and other tissues.
    Farrell F; Lee A
    Oncologist; 2004; 9 Suppl 5():18-30. PubMed ID: 15591419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells.
    Acs G; Chen M; Xu X; Acs P; Verma A; Koch CJ
    Cancer Lett; 2004 Oct; 214(2):243-51. PubMed ID: 15363551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin drives breast cancer progression by activation of its receptor EPOR.
    Chan KK; Matchett KB; Coulter JA; Yuen HF; McCrudden CM; Zhang SD; Irwin GW; Davidson MA; Rülicke T; Schober S; Hengst L; Jaekel H; Platt-Higgins A; Rudland PS; Mills KI; Maxwell P; El-Tanani M; Lappin TR
    Oncotarget; 2017 Jun; 8(24):38251-38263. PubMed ID: 28418910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The erythropoietin receptor in normal and cancer tissues.
    Jelkmann W; Bohlius J; Hallek M; Sytkowski AJ
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):39-61. PubMed ID: 18434185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.